116 related articles for article (PubMed ID: 10025579)
1. Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130.
Stübner S; Schön T; Padberg F; Teipel SJ; Schwarz MJ; Haslinger A; Buch K; Dukoff R; Lasser R; Müller N; Sunderland T; Rapoport SI; Möller HJ; Hampel H
Neurosci Lett; 1999 Jan; 259(3):145-8. PubMed ID: 10025579
[TBL] [Abstract][Full Text] [Related]
2. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.
Padberg F; Feneberg W; Schmidt S; Schwarz MJ; Körschenhausen D; Greenberg BD; Nolde T; Müller N; Trapmann H; König N; Möller HJ; Hampel H
J Neuroimmunol; 1999 Oct; 99(2):218-23. PubMed ID: 10505978
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients.
März P; Heese K; Hock C; Golombowski S; Müller-Spahn F; Rose-John S; Otten U
Neurosci Lett; 1997 Dec; 239(1):29-32. PubMed ID: 9547164
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
[TBL] [Abstract][Full Text] [Related]
5. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
Sherwin JR; Smith SK; Wilson A; Sharkey AM
J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539
[TBL] [Abstract][Full Text] [Related]
6. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters?
Kovacs E; Kuehn JJ
Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687
[TBL] [Abstract][Full Text] [Related]
7. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
[TBL] [Abstract][Full Text] [Related]
8. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
[TBL] [Abstract][Full Text] [Related]
9. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
[TBL] [Abstract][Full Text] [Related]
10. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
[TBL] [Abstract][Full Text] [Related]
12. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration.
Lehtimäki KA; Keränen T; Huhtala H; Hurme M; Ollikainen J; Honkaniemi J; Palmio J; Peltola J
J Neuroimmunol; 2004 Jul; 152(1-2):121-5. PubMed ID: 15223244
[TBL] [Abstract][Full Text] [Related]
13. Soluble gp130 regulatess interleukin-6 in cerebrospinal fluid after subarachnoid haemorrhage.
Nakura T; Osuka K; Inukai T; Takagi T; Takayasu M
J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):952-4. PubMed ID: 20660911
[TBL] [Abstract][Full Text] [Related]
14. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
15. Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients.
Kovacs E
Biomed Pharmacother; 2001 Sep; 55(7):391-6. PubMed ID: 11669502
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.
Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J
Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390
[TBL] [Abstract][Full Text] [Related]
17. Associations between serum estradiol and IL-6/sIL-6R/sgp130 complex in female patients with major depressive disorder.
Sun T; Chen Q; Mei J; Li Y
BMC Psychiatry; 2023 Oct; 23(1):742. PubMed ID: 37828513
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J
Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772
[TBL] [Abstract][Full Text] [Related]
19. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
[TBL] [Abstract][Full Text] [Related]
20. [Soluble IL-6 receptors].
Jabłońska E
Postepy Hig Med Dosw; 1998; 52(2):133-8. PubMed ID: 9640977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]